The Latest Breaking News from JNJ

Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

The S&P 500 and the Nasdaq closed the last week lower, ending the four-week winning streak on concerns over the hawkish Fed and weak economic data of some of the influential countries. However, investors should consider fundamentally sound growth stocks The Kroger (KR), Johnson & Johnson (JNJ), and Taiwan Semiconductor…

Substantial investments in R&D, an aging population, and growing demand for advanced drugs to treat chronic diseases should drive the pharmaceutical industry’s growth. Therefore, investing in fundamentally strong and dividend-paying pharma stocks Johnson & Johnson (JNJ) and Bristol-Myers Squibb (BMY) could help dodge the current market volatility and generate substantial…

Amid persistent market uncertainties due to rising inflation and a potential recession, we believe fundamentally sound, beaten-down stocks Johnson & Johnson (JNJ) and Costco Wholesale (COST) could gain solid momentum in the near term and could be wise investments now. Read on.

Due to the inelastic demand and rising investments, the healthcare sector is witnessing investor confidence amid these uncertain market conditions. Although persistent macroeconomic headwinds might affect stocks in this space, investors could consider buying dividend-paying large-cap stocks Johnson & Johnson (JNJ), Merck & Co (MRK), and UnitedHealth Group (UNH) to…

Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Rising inflation, the Fed’s hawkish stance to tame it, and an economic contraction for two consecutive quarters have stoked fears of a recession in the U.S. economy. Amid the likely economic downturn, investors could consider investing in stocks that provide a steady income in the form of dividends. Therefore, we…

Warren Buffett’s long-term value investing strategy serves as a guide for several investors amid uncertain market conditions. Thus, we think it could be wise to scoop up shares of fundamentally sound Warren Buffett holdings, The Procter & Gamble (PG), and Johnson (JNJ). Continue Reading….

Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Johnson & Johnson (NYSE: JNJ) released their financial report for the second quarter of 2022, this week, demonstrating strong growth and promising guidance for the rest of the year. Analysts seem to agree, as the consensus rating for JNJ is MODERATE BUY.

Health care bellwether Johnson & Johnson topped second-quarter expectations Tuesday, but JNJ stock fell on its trimmed 2022 outlook.